Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)

Jagsonpal Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	1,287	127.6	110.53	225.26	589.43
Short-Term Investments	-	1,352	1,036	245.31	-
Trading Asset Securities	-	-	-	-	32.51
Cash & Short-Term Investments	1,287	1,479	1,146	470.57	621.94
Cash Growth	-12.98%	29.06%	143.59%	-24.34%	56.21%
Accounts Receivable	131.76	109.51	208.72	155.77	126.64
Other Receivables	-	-	-	-	15.37
Receivables	131.76	109.51	208.72	155.77	142.01
Inventory	152	149.97	206.76	297.42	297.25
Prepaid Expenses	-	13.59	10.68	10.62	-
Other Current Assets	40.86	240.13	73.17	156.43	143.58
Total Current Assets	1,612	1,993	1,646	1,091	1,205
Property, Plant & Equipment	88.37	93.02	242.78	225.73	233.47
Long-Term Investments	173.91	47	33.84	290.55	120.58
Goodwill	96.93	-	-	0.3	0.3
Other Intangible Assets	759.24	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	23.45
Other Long-Term Assets	52.21	38.22	27.25	34.86	59.45
Total Assets	2,783	2,171	1,949	1,642	1,642
Accounts Payable	97.34	75.96	165.8	185.5	180.5
Accrued Expenses	-	81.71	88.86	79.86	89.37
Short-Term Debt	-	-	-	-	67.88
Current Portion of Leases	16.07	13.84	7.54	-	-
Current Income Taxes Payable	-	-	0.19	2.33	38.22
Current Unearned Revenue	-	12.94	6.12	-	-
Other Current Liabilities	145.63	6.83	7.2	2.03	28
Total Current Liabilities	259.04	191.28	275.71	269.72	403.97
Long-Term Leases	76.32	75.57	52.47	-	-
Long-Term Deferred Tax Liabilities	30.7	20.73	21.63	32.38	18.59
Other Long-Term Liabilities	17.04	9.18	10.75	12.56	-
Total Liabilities	383.1	296.76	360.56	314.66	422.73
Common Stock	132.8	132.19	130.99	130.99	130.99
Additional Paid-In Capital	-	111.2	6	6	6
Retained Earnings	-	1,460	1,363	1,112	1,004
Comprehensive Income & Other	2,267	170.7	88.52	78.87	78.39
Shareholders' Equity	2,400	1,874	1,589	1,328	1,219
Total Liabilities & Equity	2,783	2,171	1,949	1,642	1,642
Total Debt	92.39	89.41	60.01	-	67.88
Net Cash (Debt)	1,195	1,390	1,086	470.57	554.06
Net Cash Growth	-14.03%	27.96%	130.84%	-15.07%	65.84%
Net Cash Per Share	17.74	20.94	16.59	7.18	8.46
Filing Date Shares Outstanding	67.17	66.09	65.5	65.5	65.5
Total Common Shares Outstanding	67.17	66.09	65.5	65.5	65.5
Working Capital	1,353	1,801	1,370	821.09	800.8
Book Value Per Share	35.72	28.35	24.26	20.27	18.62
Tangible Book Value	1,543	1,874	1,589	1,327	1,219
Tangible Book Value Per Share	22.98	28.35	24.26	20.27	18.61
Land	-	-	87.59	87.59	87.59
Buildings	-	-	163.8	163.8	160.87
Machinery	-	20.38	18.02	329.61	328.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.